Beirne Wealth Consulting Services, LLC Durect Corp Transaction History

Beirne Wealth Consulting Services, LLC

$285 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.43 - $5.9 $128,832 - $1.77 Million	299,610 Added 9.76%	3,369,906 $1.95 Million
Q2 2022 Jul 13, 2022	BUY	$0.38 - $0.64 $118,037 - $198,800	310,625 Added 11.26%	3,070,296 $1.47 Million
Q1 2022 May 10, 2022	BUY	$0.55 - $0.98 $137,500 - $245,000	250,000 Added 9.96%	2,759,671 $1.85 Million
Q4 2021 Feb 03, 2022	BUY	$0.9 - $1.31 $129,477 - $188,461	143,864 Added 6.08%	2,509,671 $2.47 Million
Q3 2021 Nov 09, 2021	BUY	$1.21 - $1.61 $183,838 - $244,612	151,933 Added 6.86%	2,365,807 $3.03 Million
Q2 2021 Aug 10, 2021	BUY	$1.6 - $2.02 $166,460 - $210,156	104,038 Added 4.93%	2,213,874 $3.61 Million
Q1 2021 May 17, 2021	SELL	$1.86 - $2.87 $229,522 - $354,155	-123,399 Reduced 5.53%	2,109,836 $4.18 Million
Q4 2020 Feb 03, 2021	BUY	$1.65 - $2.43 $152,765 - $224,981	92,585 Added 4.33%	2,233,235 $4.62 Million
Q3 2020 Nov 05, 2020	BUY	$1.6 - $2.35 $264,000 - $387,750	165,000 Added 8.35%	2,140,650 $3.66 Million
Q2 2020 Jul 31, 2020	BUY	$1.33 - $2.76 $86,450 - $179,400	65,000 Added 3.4%	1,975,650 $4.58 Million
Q1 2020 Apr 28, 2020	BUY	$0.97 - $2.85 $247,014 - $725,763	254,654 Added 15.38%	1,910,650 $2.96 Million
Q4 2019 Jan 14, 2020	BUY	$1.69 - $3.8 $207,432 - $466,415	122,741 Added 8.01%	1,655,996 $6.29 Million
Q3 2019 Nov 07, 2019	BUY	$0.61 - $2.21 $168,860 - $611,772	276,820 Added 22.03%	1,533,255 $2.82 Million
Q2 2019 Jul 25, 2019	SELL	$0.51 - $0.86 $26,457 - $44,614	-51,877 Reduced 3.97%	1,256,435 $819,000
Q1 2019 May 14, 2019	BUY	$0.51 - $0.82 $84,615 - $136,047	165,912 Added 14.52%	1,308,312 $819,000
Q4 2018 Feb 14, 2019	BUY	$0.48 - $1.1 $548,352 - $1.26 Million	1,142,400 New	1,142,400 $552,000

Others Institutions Holding DRRX

# of Institutions

Shares Held

593K

Call Options Held

Put Options Held

View Full List

About DURECT CORP

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $216M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

More about DRRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beirne Wealth Consulting Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beirne Wealth Consulting Services, LLC with notifications on news.

Account